Vera Therapeutics — Looking forward to publishing 96-week full data from the Phase 2B origin trial. The trial is expected to be released in the fourth quarter of this year
Vera Therapeutics——期待公布2B期原产地试验的96周完整数据该试验预计将于今年第四季度发布
Vera Therapeutics — Looking forward to publishing 96-week full data from the Phase 2B origin trial. The trial is expected to be released in the fourth quarter of this year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.